CAS: 1309-33-7; Iron(Iii) Hydroxide

该化合物是一种无机化合物,表面上是红褐色固体,主要通过水溶液中氟化盐的水解形成.氢氧化铁在水中溶解,在各种应用中有用,包括水处理过程,它作为凝固剂,可以去除杂质.它具有相对较低的溶解性产品,导致碱性条件下的降水.化合物为氨化,这意味着它可以与酸和碱基发生反应,形成溶性复合物或盐.氧化铁也是其他铁化合物的前体,如氧化铁,并且用于造色和某些化学反应中的催化剂.此外,它还在生物系统中发挥作用,特别是在铁的代谢中.安全考虑包括它与皮肤或眼睛接触后可能造成刺激,并观察适当的处理措施.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号80937-33-3 oxygen | CAS号7439-89-6 铁粉

合成工艺路线路线简述

  • 合成目标产物 Iron Hydroxide 主要起始原料 Ethanamine, N-[(3,5-Dichlorophenyl)Methylene]-2,2-Diethoxy- And Iron
  • (文献来源)合成步骤主要原料 Ethanamine, N-[(3,5-Dichlorophenyl)Methylene]-2,2-Diethoxy- 和 Iron
Ferric Nitrate 反应生成氢氧化铁
参考文献:Edwards,Marc;Benjamin,Mark M.,Res. J. Water Pollut. Contr. Fed,61,(1989) N,C. 1523-1533
标题:Edwards,Marc;Benjamin,Mark M.,Res. J. Water Pollut. Contr. Fed,61,(1989) N,C. 1523-1533

专利信息


专利号:US-9011694-B2
优先权日:2010-09-28
标 题 :Method for the synthesis of tetravalent manganese feroxyhite for arsenic removal from water
发明人:MITRAKAS MANASSIS; SYMEONIDIS KONSTANTINOS; TRESINTSI SOFIA
权利人:MITRAKAS MANASSIS; SYMEONIDIS KONSTANTINOS; TRESINTSI SOFIA; LOUFAKIS CHEMICALS S A
摘要:The present invention refers to a method for the synthesis of an adsorbing material consisting of a single-phase tetravalent manganese feroxyhite (Å?-Fe (1-x) Mn x OOH), in which a percentage of 0.05 to 25% of iron atoms has been isomorphically substituted by Mn(IV) atoms. Its production takes place in a continuous two-stage flow reactor at weakly acidic conditions (pH 4-7) and high redox (300-800 mV). The material can be used for the removal of both pentavalent and trivalent arsenic as well as other heavy metals form water. More specifically, its adsorption capacity and selectivity depending on the trivalent and pentavalent arsenic water content, are determined by the manganese percentage and the compact or hollow morphology of its structural unit which can be both controlled by the parameters of the synthesis procedure.

专利号:WO-2012001578-A1
优先权日:2010-06-29
标 题 :Single-step synthesis of iron oxide nanoparticles
发明人:BURDINSKI DIRK; HAEX NICOLE PETRONELLA MARTIEN
权利人:KONINKL PHILIPS ELECTRONICS NV; BURDINSKI DIRK; HAEX NICOLE PETRONELLA MARTIEN
摘要:The invention provides methods for the synthesis of iron oxide nanoparticles and the particles obtainable by these methods. The particles can be used as tracer materials for magnetic particle imaging and for Magnetic Particle Spectroscopy (MPS). The method for the synthesis of these particles comprises the steps: (i) dissolving at least one water-soluble iron salt and at least one water-soluble stabilizer in water to form a reaction batch, (ii) adding at least one base to the reaction batch to yield a pH of 10 to 13, and (iii) exposing the reaction batch to a reaction temperature T R for a defined period of time DT, wherein T R ≥ 110°C, to obtain the iron oxide nanoparticles.

专利号:US-7759520-B2
优先权日:1996-11-27
标 题 :Synthesis of selective androgen receptor modulators
发明人:DALTON JAMES T; MILLER DUANE D; YIN DONGHUA; HE YALI
权利人:UNIV TENNESSEE RES FOUNDATION
摘要:The present invention relates to a synthetic process for the preparation of a novel class of androgen receptor targeting agents (ARTA) which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds which are selective androgen receptor modulators (SARM) which are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, benign prostate hyperplasia, alterations in mood and cognition and prostate cancer; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, endometriosis, breast cancer, uterine cancer and ovarian cancer; d) treatment and/or prevention of chronic muscular wasting; e) decreasing the incidence of, halting or causing a regression of prostate cancer; f) oral androgen relacement and/or other clinical therpauetic and/or diagnostic areas. The process of the present invention is suitable for large-scale preparation, since all of the steps give rise to highly pure compounds, thus avoiding complicated purification procedures which ultimately lower the yield. Thus the present invention provides methods for the synthesis of non-steroidal agonist compounds, that can be used for industrial large-scale synthesis, and that provide highly pure products in high yield.

专利号:US-6995284-B2
优先权日:2000-08-24
标题 :Synthesis of selective androgen receptor modulators
发明人:DALTON JAMES T; MILLER DUANE D; HE YALI; YIN DONGHUA
权利人:UNIV TENNESSEE RES FOUNDATION
摘要:The present invention relates to a synthetic process for the preparation of a novel class of androgen receptor targeting agents (ARTA) which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds which are selective androgen receptor modulators (SARM) which are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, benign prostate hyperplasia, alterations in mood and cognition and prostate cancer; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, endometriosis, breast cancer, uterine cancer and ovarian cancer; d) treatment and/or prevention of chronic muscular wasting; e) decreasing the incidence of, halting or causing a regression of prostate cancer; f) oral androgen relacement and/or other clinical therpauetic and/or diagnostic areas. The process of the present invention is suitable for large-scale preparation, since all of the steps give rise to highly pure compounds, thus avoiding complicated purification procedures which ultimately lower the yield. Thus the present invention provides methods for the synthesis of non-steroidal agonist compounds, that can be used for industrial large-scale synthesis, and that provide highly pure products in high yield.

专利号:US-2023286918-A1
优先权日:2020-07-02
标 题:Manufacturing process for 3,5-dichloropicolinonitrile for synthesis of vadadustat
发明人:JURKAUSKAS VALDAS; JUNG YOUNG CHUN; KWON TAESOO; KANNAN ARUNACHALAM; GONDI VIJAYA BHASKER
权利人:AKEBIA THERAPEUTICS INC
摘要:Disclosed herein are methods and processes of preparing vadadustat or a pharmaceutically acceptable salts thereof, and intermediates (e.g., a compound of Formula (I), (I-F), (II), or (IV), or a pharmaceutically acceptable salts thereof) useful for the synthesis of vadadustat.

专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
温州吉象化学股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.cnjxchem.com
企业联系电话:86-577-88799961 88795800(总机) 88799963👤
📞温州吉象化学股份有限公司 ⚠️参考联系方式
联系人:李司元
电话:86-577-88799961 88795800(总机) 88799963

传真:86-577-88790887
邮箱:sales@cnjxchem.com
通信地址: 温州市沿江工业园区33号地块
邮编: 325008
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:温州市沿江工业园区33号地块
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
沈阳子仲化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.zizhongchem.com
企业联系电话:13609876053👤
📞沈阳子仲化工有限公司 ⚠️参考联系方式
联系人:张总
电话:13609876053
手机:13609876053

邮箱:13609876053@139.com
通信地址: 辽宁省沈阳市浑南区全运三路99-1号
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:辽宁省沈阳市浑南区全运三路99-1号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
南通市众望添加剂有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.sudong-chem.com
电话: 0086-513-84586588👤
📞南通市众望添加剂有限公司 ⚠️参考联系方式

销售电话:0086-513-84586588
邮箱:wm@sudong-chem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
廊坊乾耀科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.pc-chem.com
企业联系电话:15532638102👤
📞廊坊乾耀科技有限公司 ⚠️参考联系方式
联系人:陈雪
电话:15532638102
手机:15532638102
传真:天津乾耀科技有限公司 15532638102
邮箱:bjjhtyhg@163.com
通信地址: 河北省廊坊市大城工业园区现代制造业工业园
邮编: 100022
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:河北省廊坊市大城工业园区现代制造业工业园
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
重庆亚翔龙生物医药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.yaxianglong.com
企业联系电话:023-40812010;0812523👤
📞重庆亚翔龙生物医药有限公司 ⚠️参考联系方式
联系人:张小姐
电话:023-40812010;0812523
手机:18008345763;17783591035
传真:023-40720172
邮箱:QQ:3007199072;3007224121;3007198410;3007198508
通信地址: 重庆市长寿区晏家街道育才路5号3-1
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:重庆市长寿区晏家街道育才路5号3-1
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海亚毓生物医药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.yayupharm.com
企业联系电话:021-54370255👤
📞上海亚毓生物医药有限公司 ⚠️参考联系方式
联系人:王经理
电话:021-54370255
手机:13862662808
传真:021-54370255
邮箱:yayu@yalongchina.net
通信地址: 上海市金山区金山卫镇秋实路688号
邮编: 201515
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市金山区金山卫镇秋实路688号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
安康兰之光环保科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.languangchem.com
企业联系电话:13669193868👤
📞安康兰之光环保科技有限公司 ⚠️参考联系方式
联系人:闵宝珠
电话:13669193868
手机:13669193868
传真:029-88514362
邮箱:languang@languangchem.com
通信地址: 安康市汉滨区五里工业集中区(东区)
邮编: 725018
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:安康市汉滨区五里工业集中区(东区)
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:MOWRY RW. Improved procedure for the staining of acidic polysaccharides by Müller's colloidal (hydrous) ferric oxide and its combination with the Feulgen and the periodic acid-Schiff reactions. Lab Invest. 1958 Nov;7(6):566–76.
参考文献:10.1093/ndt/gfl289
摘要:Savica V, Calò LA, Monardo P, Santoro D, Bellinghieri G. Phosphate binders and management of hyperphosphataemia in end-stage renal disease. Nephrol Dial Transplant. 2006 Aug;21(8):2065–8. doi: 10.1093/ndt/gfl289.
参考文献:10.1021/es071553d
摘要:Zeng H, Fisher B, Giammar DE. Individual and competitive adsorption of arsenate and phosphate to a high-surface-area iron oxide-based sorbent. Environ Sci Technol. 2008 Jan 01;42(1):147–52. doi: 10.1021/es071553d.
参考文献:10.1021/jacs.9b03329
摘要:Yadav V, Gordon JB, Siegler MA, Goldberg DP. Dioxygen-Derived Nonheme Mononuclear FeIII(OH) Complex and Its Reactivity with Carbon Radicals. J. Am. Chem. Soc. 2019 Jun 20;141(26):10148–53. doi: 10.1021/jacs.9b03329.
参考文献:10.1128/aem.50.6.1502-1504.1985
摘要:Farrah SR, Preston DR. Concentration of viruses from water by using cellulose filters modified by in situ precipitation of ferric and aluminum hydroxides. Appl Environ Microbiol. 1985 Dec;50(6):1502–4. doi: 10.1128/aem.50.6.1502-1504.1985.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知